RADPAINT-2NCT04910308
RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and Neck
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 5 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria revised Show 5 more changesShow less
- Trial completed
- Study completion date changed from estimate of Aug 2025 to Jun 20, 2025
- Secondary endpoints: details revised at 3 of 5 entries
- Study description revised
- Publications: details revised at 1 of 1 entry
- Minor Study completion date: Dec 31, 2024 to Aug 2025v6
- Minor Trial status: Recruiting to Active, Not Recruiting
- Primary completion date changed from estimate of Jun 30, 2022 to May 27, 2022
- Site details revised
- Notable Trial status: Not Yet Recruiting to Recruiting
- Primary completion date: Jun 30, 2021 to Jun 30, 2022
- Start date changed from estimate of Jun 1, 2021 to Jul 1, 2021
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Late toxicity - mucosal ulcer
Timeframe: 1 year
Acute or late toxicity
Timeframe: 1 year
Secondary (5)
Acute toxicity
Late toxicity
Loco-regional control
Disease free survival
Overall survival
Arms and interventions
Dose paintingExperimental
Dose painting
Radiation: FDG-PET guided dose painting
Sites
1 site in 1 country
- Oslo University HospitalOslo, Norway